One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases-Reference-Cited by-同舟云学术

One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases

Published:2016-11-14 Issue:4 Volume:44 Page:375-385
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Yagami Akiko¹,Furue Masutaka²,Togawa Michinori³,Saito Akihiro³,Hide Michihiro⁴

Affiliation:

1. Department of Dermatology; School of Medicine; Fujita Health University; Aichi Japan

2. Department of Dermatology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan

3. Clinical Development Division; TAIHO Pharmaceutical; Tokyo Japan

4. Department of Dermatology; Institute of Biomedical and Health Sciences; Hiroshima University; Hiroshima Japan

Funder

Taiho Pharmaceutical

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13644/fullpdf

Reference25 articles.

1. Effect of the pruritus on the quality of life: a preliminary study;Erturk;Ann Dermatol,2012

2. Factors mediating the impact of chronic pruritus on quality of life;Carr;JAMA Dermatol,2014

3. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases;Murota;Allergol Int,2010

4. Clinical classification of itch: a position paper of the International Forum for the Study of Itch;Ständer;Acta Derm Venereol,2007

5. Chronic pruritus-pathogenesis, clinical aspects and treatment;Metz;J Eur Acad Dermatol Venereol,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial;European Journal of Pharmaceutical Sciences;2024-12

2. Exploring the safety profile of bilastine in chronic spontaneous urticaria: A real-world analysis in the Indian population;Indian Journal of Dermatology, Venereology and Leprology;2024-07-11

3. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

4. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

5. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study;Drugs in Context;2024-05-01